☆ 4.6 Editorial Material

Remyelination and neuroprotective effects of alemtuzumab therapy in patients with multiple sclerosis

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2021)

Journal

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Volume 92, Issue 12, Pages 1251-1251

Publisher

BMJ PUBLISHING GROUP

DOI: 10.1136/jnnp-2021-326821

Keywords

multiple sclerosis

Categories

Clinical Neurology Psychiatry Surgery

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper

Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6

Not enough ratings

Secondary Ratings

Novelty

-

Significance

-

Scientific rigor

-

Rate this paper

Recommended

No Data Available

No Data Available

No Data Available

© Peeref 2019-2024. All rights reserved.